|
117 Sanofi-Aventis
restricts supply to three wholesalers Sanofi-Aventis has reduced the number of wholesalers that will supply its products “to improve supply chain efficiency and integrity”, hot on the heels of a similar announcement by Napp Pharmaceuticals, reported last week
PJ 2007;279:117
Full Text
117 MHRA reprimands two manufacturers
over advertisements Schering-Plough and
Servier have been admonished by the Medicines and Healthcare products
Regulatory Agency over misleading advertisements
PJ 2007;279:117
Full Text
117 Fees petition gathers pace Disgruntled pharmacists have signed an online petition protesting against the Royal Pharmaceutical Society's planned rise in the retention fee from £283 to £425
PJ 2007;279:117
Full Text
117 Scottish community pharmacists get remuneration
update Pharmacy contractors in Scotland will be sent a financial framework document this week by Community Pharmacy Scotland setting out how remuneration in 2007–08 will be structured
PJ 2007;279:117
Full Text
118 Government response to
Galbraith to form part of new White Paper A White
Paper that will set out future proposals for developing pharmaceutical services
is to be published by the Department of Health in the autumn (2007)
PJ 2007;279:118
Full Text
118 Alliance Boots changes management structure Alliance
Boots has this week announced changes to its subsidiary companies' senior management
structures following its transfer to private ownership
PJ 2007;279:118
Full Text
118 SE London chlamydia pilot improves access
for women Community pharmacy is a suitable setting
for chlamydia testing and treatment, according to a published evaluation of a
south-east London pilot
PJ 2007;279:118
Full Text
118 Public review of NHS boards Members
of the public are being given the opportunity to participate in Scottish NHS
board performance reviews for the first time
PJ 2007;279:118
Full Text
118 Late surgeries for Scottish GPs Doctors
in Scotland might be asked to move some of their surgeries to the evenings, with
daytime telephone calls being diverted to NHS24
PJ 2007;279:118
Full Text
119 More work needed if AfC
is to improve patient care Agenda for Change, the
pay system for NHS staff rolled out nationally in 2004, is unlikely to fulfil
its potential in terms of improving patient care, or be worth its cost, unless
more systematic efforts are made to use it in the way it was intended, a King's
Fund report concludes
PJ 2007;279:119
Full Text
119 CPW chief executive retires Peter
Hayden Jones is to stand down as chief executive of Community Pharmacy Wales
on 1 September 2007
PJ 2007;279:119
Full Text
119 Welsh trust mergers proposed Proposed
mergers of several NHS trusts, which are designed to streamline management, have
been supported in principle by Welsh Health Minister Edwina Hart
PJ 2007;279:119
Full Text
119 Mental health patients not told of side
effects Over a third of people with schizophrenia
are given no information about the side effects of their medicines, a review
of community mental health services in England has found
PJ 2007;279:119
Full Text
119 First-in-man clinical trial guidelines published
by the EMEA Strategies to identify and mitigate
risks in first-in-man clinical trials have been set out by the European Medicines
Agency (EMEA)
PJ 2007;279:119
Full Text
120 First consultant pharmacist
to work across cancer network and NHS trust appointed in north-east Steve
Williamson has been appointed consultant pharmacist for cancer services, the
first such pharmacist to work across a cancer network and an acute NHS trust
PJ 2007;279:120
Full Text
120 HPA issues health advice for people living
in flood-affected areas Health advice for people
living in areas affected by flooding has been issued by the Health Protection
Agency
PJ 2007;279:120
Full Text
120 Post-exposure prophylaxis for HIV changed Recommendations
for HIV post-exposure prophylaxis (PEP) have been changed following last month's
recall of nelfinavir (Viracept). Lopinavir/ritonavir (Kaletra) tablets should
be substituted for nelfinavir in PEP starter packs
PJ 2007;279:120
Full Text
120 Hib catch-up campaign A catch-up programme for young children who have not been immunised with the Haemophilus
influenzae type b (Hib) vaccine will start in England on 10 September 2007
PJ 2007;279:120
Full Text
121 LPC gathering evidence
to support commissioning Evidence to support commissioning
of new pharmacy services is to be gathered as part of a medicines use review
initiative being delivered across Hampshire and the Isle of Wight
PJ 2007;279:121
Full Text
121 Computers on a par with medical staff when
calculating anticoagulant dose changes Computers
are as good as trained medical staff at calculating anticoagulant dose adjustments,
a study involving over 13,000 patients has found
PJ 2007;279:121
Full Text
121 Eflornithine not first-line treatment for
hirsutism, DTB says Eflornithine cream
should not be used first-line to treat women with facial hirsutism, this month's
DTB suggests
PJ 2007;279:121
Full Text
121 Varenicline endorsed by NICE Varenicline
has been endorsed for use in the NHS in England and Wales by the National Institute
for Health and Clinical Excellence
PJ 2007;279:121
Full Text
121 Compass set for national roll out National
roll-out of Compass, one of Lloydspharmacy's electronic prescription service-compatible
pharmacy systems, has been authorised by NHS Connecting for Health
PJ 2007;279:121
Full Text
121 Non-GP work in surgeries rises Patient consultations undertaken by “other clinicians” — a group which includes pharmacists — have doubled from 2 per cent to 4 per
cent in general practice over the past decade, a report, published this week by The Information Centre, indicates
PJ 2007;279:121
Full Text
122 Combination treatment
increases survival in CLL Treatment of chronic
lymphocytic leukaemia (CLL) with fludarabine plus cyclophosphamide increases
response rates and progression-free survival compared with single agent fludarabine
or chlorambucil, according to research published last month
PJ 2007;279:122
Full Text
122 Low levels of LDL cholesterol associated
with increased cancer risk Evidence for an association
between low levels of low-density lipoprotein cholesterol (LDL-C) and increased
cancer risk is published this week. However, the researchers emphasise that the
relationship does not imply causality but is hypothesis-generating and requires
further investigation
PJ 2007;279:122
Full Text |
The
Pharmaceutical Journal